Home NDC 72694-728-40 VORANIGO
Product NDC 72694-728
Requested package NDC 72694-728-40
11-digit product format 726940728
Labeler code 72694
Product ID 72694-728_ee016d13-6ef7-4e50-bb23-d8ece41d549d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name vorasidenib
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Servier Pharmaceuticals LLC
Application NDA218784
Marketing category NDA
Marketing start 2024-08-07
Substance VORASIDENIB
Active strength 40 mg/1
Pharmacologic classes Cytochrome P450 3A Inducers [MoA], Isocitrate Dehydrogenase 1 Inhibitor [EPC], Isocitrate Dehydrogenase 1 Inhibitors [MoA], Isocitrate Dehydrogenase 2 Inhibitor [EPC], Isocitrate Dehydrogenase 2 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218784-001 VORANIGO VORASIDENIB 10MG TABLET / ORAL RLD 2024-08-06 N218784-002 VORANIGO VORASIDENIB 40MG TABLET / ORAL RLD, RS 2024-08-06
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218784-001 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 N218784-001 12433895 2034-07-11 U-4286 2025-10-22 N218784-001 9579324 2034-07-11 Drug substance 2024-08-27 N218784-001 11844758 2035-12-04 U-3977 2024-08-27 N218784-001 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 N218784-002 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 N218784-002 12433895 2034-07-11 U-4286 2025-10-22 N218784-002 9579324 2034-07-11 Drug substance 2024-08-27 N218784-002 11844758 2035-12-04 U-3977 2024-08-27 N218784-002 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 c2088c7a36db…2026-09-14 22:38:34 2026-08 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218784-001 VORANIGO 10MG TABLET / ORAL RLD 2024-08-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218784-002 VORANIGO 40MG TABLET / ORAL RLD, RS 2024-08-06 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 134 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N218784-001 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-001 12433895 2034-07-11 U-4286 2025-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-001 9579324 2034-07-11 Drug substance 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-001 11844758 2035-12-04 U-3977 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-001 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 12433895 2034-07-11 U-4286 2025-10-22 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 9579324 2034-07-11 Drug substance 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 11844758 2035-12-04 U-3977 2024-08-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218784-002 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N218784-001 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-001 12433895 2034-07-11 U-4286 2025-10-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-001 9579324 2034-07-11 Drug substance 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-001 11844758 2035-12-04 U-3977 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-001 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 12433895 2034-07-11 U-4286 2025-10-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 9579324 2034-07-11 Drug substance 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 11844758 2035-12-04 U-3977 2024-08-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218784-002 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N218784-001 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-001 12433895 2034-07-11 U-4286 2025-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-001 9579324 2034-07-11 Drug substance 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-001 11844758 2035-12-04 U-3977 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-001 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 12433895 2034-07-11 U-4286 2025-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 9579324 2034-07-11 Drug substance 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 11844758 2035-12-04 U-3977 2024-08-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218784-002 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218784-001 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-001 12433895 2034-07-11 U-4286 2025-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-001 9579324 2034-07-11 Drug substance 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-001 11844758 2035-12-04 U-3977 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-001 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 10172864 2034-07-11 Drug substance, Drug product 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 12433895 2034-07-11 U-4286 2025-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 9579324 2034-07-11 Drug substance 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 11844758 2035-12-04 U-3977 2024-08-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218784-002 11345677 2039-01-16 U-3978 Drug substance, Drug product 2024-08-27 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 60 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base VORANIGO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VORASIDENIB 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 789Q85GA8P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2690653 Internal RxNorm lookup 2690659 Internal RxNorm lookup 2690661 Internal RxNorm lookup 2690663 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72694-728-40 VORANIGO 30 in 1 BOTTLE TABLET, FILM COATED 30 4 72694-728-40 VORANIGO 1 in 1 CARTON TABLET, FILM COATED 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72694-728 VORANIGO (VORASIDENIB) TABLET, FILM COATED [SERVIER PHARMACEUTICALS LLC] 4 Current NDC, 2 package rows 20250410_31405fee-55b7-4857-987e-2724ee76be84.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72694-728-40 72694072840 1 BOTTLE in 1 CARTON (72694-728-40) / 30 TABLET, FILM COATED in 1 BOTTLE 1 bottle 2024-08-07 No No Current